bokomslag RNA Nanotechnology and Therapeutics
Kropp & själ

RNA Nanotechnology and Therapeutics

Peixuan Guo Farzin Haque

Inbunden

1529:-

Funktionen begränsas av dina webbläsarinställningar (t.ex. privat läge).

Uppskattad leveranstid 7-11 arbetsdagar

Fri frakt för medlemmar vid köp för minst 249:-

Andra format:

  • 239 sidor
  • 2015
This volume contains a compilation of techniques and laboratory protocols directly related to RNA nano technology and its applications in nano biotechnology and nano medicine. The chapters in this book cover a wide range of research methods that can be easily comprehended and carried out in a step-by-step manner by graduate students and postdoctoral fellows from diverse scientific disciplines. Some of the covered topics include various biochemical, biophysical and bioinformatics approaches for analyzing RNA structures and properties; methods to analyze the multi-step assembly process of RNA nano architectures; purification of multifunctional RNA nanoparticles by ultracentrifugation and HPLC; real-time detection of RNA nano constructs in vivo; conjugation of imaging, targeting and therapeutic modules to RNA scaffold; and design and characterization of RNA-protein nanostructures. Written in the highly successful Methods of Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols and key tips on troubles troubleshooting and avoiding known pitfalls. Cutting-edge and practical, RNA Nanotechnology and Therapeutics: Methods and Protocols propels the field toward new heights by engaging researchers working in the diverse fields of physical, engineering, and life sciences.
  • Författare: Peixuan Guo, Farzin Haque
  • Illustratör: 4 schwarz-weiße Tabellen 21 schwarz-weiße und 48 farbige Abbildungen Bibliographie
  • Format: Inbunden
  • ISBN: 9781493925612
  • Språk: Engelska
  • Antal sidor: 239
  • Utgivningsdatum: 2015-04-21
  • Förlag: Humana Press Inc.